PATENT CLAIM ANALYSIS

Application Number: 16292473
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "561000"]

Abstract:
A method for relieving menstrual pain and reducing menstrual blood loss in a female is provided. The method comprises administering to the female an oral combination drug formulation comprising a first therapeutically effective dose of a non-steroidal anti-inflammatory drug (NSAID) and a second complementary low dose of tranexamic acid, wherein the NSAID is formulated to relieve the menstrual pain and to reduce a volume of menstrual blood loss of the female, wherein the dose of tranexamic acid ranges from 50 mg to 425 mg per oral combination drug formulation.

Claim (Index 7):
The method of  claim 1 , wherein the female has a condition that comprises any one of: primary dysmenorrhea, secondary dysmenorrhea, menorrhagia, idiopathic menorrhagia, cyclic heavy menstrual bleeding, dysfunctional uterine bleeding, anemia, menstrual bleeding of less than 80 ml per menstrual cycle, and menstrual bleeding of more than 80 ml per menstrual cycle.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 99.0
- Lexical Diversity: 1.75926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12714181', '12433510', '13016800', '13230902', '14017530']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7890902021747969
- 35 USC 102 Novelty (BERT): 0.5392517627538024
- Combined Prediction Score: 0.7641063582326975
- Mean Citation Score: 351.910706
- Max Citation Score: 386.66403
- Similarity Product: 222.91736706216216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test